Cryptophycin: A New Antimicrotubule Agent Active against Drug-resistant Cells

Cancer Research

Volumn 54, Issue 14, 1994, Pages 3779-3784

  Smith, Charles D ^a   Zhang, Xinqun ^a   Mooberry, Susan L ^a   Patterson, Gregory M L ^a   Moore, Richard E ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CRYPTOPHYCIN; UNCLASSIFIED DRUG; VIMENTIN; VINBLASTINE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CYANOBACTERIUM; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MICROFILAMENT; MICROTUBULE; MITOSIS; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; CYTOCHALASIN B; DRUG RESISTANCE; HUMAN; MICE; MICROTUBULES; MITOTIC INDEX; PACLITAXEL; PEPTIDES, CYCLIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0028141462     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rowinsky, E.K., and Donehower, R.C. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol. Ther., 52: 35-84, 1991.
2. Hamel, E. Interactions of tubulin with small ligands. In: J. Avila (ed.), Microtubule Proteins, pp. 89-191. Boca Raton, FL: CRC Press, 1990.
3. Deconti, R.C., and Creasey, W.A. Clinical aspects of the dimeric Catharathus alkaloids. In: W.I. Taylor and N.R. Farnsworth (eds.), The Catharanthus Alkaloids: Botany, Chemistry, Pharmacology and Clinical Use, pp. 237-278, New York: Marcel Dekker, 1975.
4. Gerzon, K. Dimeric Catharanthus alkaloids. In: J.M. Cassady and J.D. Douros (eds.), Anticancer Agents Based on Natural Product Models, pp. 271-331.a New York: Academic Press, 1980.
5. Taylor, E.W. The mechanism of colchicine inhibition of mitosis. J. Cell Biol., 25: 145-160, 1965.
6. Hartley-Asp, B. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines, DU 145 and PC-3. Prostate, 5: 93-100, 1984.
7. Stearns, M.E., and Tew, K.D. Anti-microtubule effects of estramustine, an anti-prostatic tumor drug. Cancer Res., 45: 3891-3897, 1985.
8. Bai, R., Paull, K.D., Herald, C.L., Malspeis, L., Pettit, G.R., and Hamel, E. Halichondrin B and homohalichondrin B, marine natural products binding to the Vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem., 266: 15882-15889, 1991.
9. Sullivan, A.S., Prasad, V., Roach, M.C., Takahashi, M., Iwasaki, S., and Luduena, R.F. Interaction of rhizoxin with bovine brain tubulin. Cancer Res., 50: 4277-4280, 1990.
10. Huang, A.B., Lin, C.M., and Hamel, E. Maytansine inhibits nucleotide binding at the exchangable site of tubulin. Biochem. Biophys. Res. Commun., 128: 1239-1246, 1985.
11. Luduena, R.F., Prasad, V., Roach, M.C., and Lacey, E. The interactions of phomopsin A with bovine brain tubulin. Arch. Biochem. Biophys., 272: 32-38, 1989.
12. Bai, R., Pettit, G.R., and Hamel, E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the Vinca alkaloid binding domain. Biochem. Pharmacol., 39: 1941-1949, 1990.
13. Schwartz, R.E., Hirsch, C.F., Sesin, D.F., Flor, J.E., Chartrain, M., Fromtling, R.E., Harris, G.H., Salvatore, M.J., Liesch, J.M., and Yudin, K. Pharmaceuticals from cultured algae. J. Indust. Microbiol., 5: 113-124, 1990.
14. Hirsch, C.F., Liesch, J.M., Salvatore, M.J., Schwartz, R.E., and Sesin, D.F. Antifungal fermentation product and method. U.S. Patent No. 4, 946, 835, 1990.
15. Trimurtulu, G., Ohtani, I., Patterson, G.M.L., Moore, R.E., Corbett, T.H., Valeriote, F.A., and Demchik, L. Total structures of cryptophycins, potent antitumor depsipep-tides from the blue-green alga Nostoc sp. Strain GSV 224. J. Am. Chem. Soc., in press, 1994.
16. Bradley, G., Naik, M., and Ling, V. P-glycoprotein expression in multidrug resistant human ovarian carcinoma cell lines. Cancer Res., 49: 2790-27%, 1989.
17. Skehan, P., Stoneng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
18. Patterson, G.M.L., Smith, C.D., Kimura, L.H., Britten, B., and Carmeli, S. Action of tolytoxin on cell morphology and cytoskeletal structure in vitro. Cell Motil. Cytoskeleton, 24: 39-48, 1993.
19. Fairchild, C.R., Ivy, S.P., Kao-Shan, C.S., Whang-Peng, J., Rosen, N., Isreal, M.A., Melera, P.W., Cowan, K.H., and Goldsmith, M.E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
20. Jordan, M.A., Thrower, D., and Wilson, L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res., 51: 2212-2222, 1991.
21. Cutts, J.H. The effect of Vincaleukoblastine on dividing cells in vivo. Cancer Res., 21: 168-172, 1961.
22. Howard, S.M.H., Theologides, A., and Shepard, J.R. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Cancer Res., 40: 2695-2700, 1980.
23. Palmer, C.G., Livengood, D., Warren, A.K., Simpson, P.J., and Johnson, I.S. The action of vincaleukoblastine on mitosis in vitro. Exp. Cell Res., 20: 198-202, 1960.
24. Ball, E.H., and Singer, S.J. Mitochondria are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc. Natl. Acad. Sci. USA, 79: 123-126, 1982.
25. Schiff, P.B., and Horwitz, S.B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
26. Manfredi, J.J., and Horwitz, S.B. Taxol: an antimitotic agent with a new mechanism of action. Pharmacol. Ther., 25: 83-125, 1984.
27. Na, G.C., and Timasheff, S.N. In vitro vinblastine-induced tubuin paracrystals. J. Biol. Chem., 257: 10387-10391, 1982.
28. Endicott, J.A., and Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58: 137-171, 1989.
29. Beck, W.T. The cell biology of multiple drug resistance. Biochem. Pharmacol., 36: 2879-2887, 1987.
30. Moscow, J.A., and Cowan, K.H. Multidrug resistance. J. Natl. Cancer Inst., 80: 14-20, 1988.
31. Akiyama, S.I., Fojo, A., Hanover, J.A., Pastan, I., and Gottesman, M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet., 11: 117-126, 1985.
32. Minotti, A.M., Barlow, S.B., and Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J. Biol. Chem., 266: 3987-3994, 1991.
33. Smith, C.D., Carmeli, S., Moore, R.E., and Patterson, G.M.L. Scytophycins: novel microfilament-depolymerizing agents which circumvent P-glycoprotein mediated multidrug resistance. Cancer Res., 53: 1343-1347, 1993.